US FDA's Breakthrough Program Needs Higher Standard For Comparators, NEJM Says

Harvard Medical School researchers call for inclusion of off-label drugs, accelerated approvals, and dietary supplements in the definition of 'existing therapies.'

SC1802_Lego Wall_658035112_1200.jpg

More from R&D

More from Pink Sheet